THERORNA
associated with 5 other trademarks
Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, l...

Words that describe this trademark:

medical purposes  drugs medical  pharmaceutical preparations  biological preparations  purposes  medicines  preparations  vaccines  serotherapeutic 

Serial Number:

90796130

Mark:

THERORNA

Status:

Registered

Status Date:

09-12-2023

Filing Date:

Registration Number:

7159975

Registration Date:

09-12-2023

Goods and Services:

Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; opotherapy preparations; serotherapeutic medicines, namely, medical immune serums used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; biological preparations for medical purposes, namely, biological preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; medicines for human purposes, namely, medicines used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; chemical preparations for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; adjuvants for medical purposes; Blood for medical purposes; nutraceutical preparations for therapeutic or medical purposes; immunostimulants; Medical cell function activating drugs, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; tumor suppressing agents; Anti-sarcoma preparations; cytostatics for medical purposes; Pharmaceutical products for the prevention and treatment of cancer; all the foregoing using circular ribonucleic acid (RNA)

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

06-27-2023

Mark Drawing Status:

Words, Letters, and/or Numbers in Stylized From

Abandon Date:

N/A

Business Name:

PATEL & ALMEIDA, P. C.

Correspondent Name:

Recent Trademark filings by this company